Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01386801 · ClinicalTrials.gov registry record
Multicenter Research Study to Build a Repository to Study Chronic Diseases in Indiana
A clinical trial of Diabetes Mellitus Type II, sponsored by Fairbanks Institute.
- Active
- Registry status
- 1,000
- Enrollment target
- 11
- Study locations
NCT01386801: Active study of Diabetes Mellitus Type II, sponsored by Fairbanks Institute.
NCT01386801 is a study of Diabetes Mellitus Type II that is active but no longer recruiting, run by Fairbanks Institute. The registered enrollment target is 1,000 participants, above the 97-participant average among 7 other Diabetes Mellitus Type II trials with a reported enrollment target (931% higher). The trial reports 11 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01386801, a study of Diabetes Mellitus Type II, is active but no longer recruiting, sponsored by Fairbanks Institute.
- ACTIVE NOT RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 11
- Study locations
Study Summary
Blood samples and health information (e.g., age at diagnosis, test results) are collected for the purposes of genetic research. The blood samples are assigned a number and stored in a repository for safe keeping until they are needed for a research project. Participants are persons who are healthy (not having high blood pressure, diabetes, or high cholesterol levels) or persons who have Diabetes Mellitus Type II(T2D) and live in Indiana. Participants complete a questionnaire at the time the blood sample is drawn. Visits are repeated at 2 and 5 years after initial contact. Researchers apply to the Fairbanks Institute for use of the blood samples and health information minus participant names and contact information. Their research is required to be related to find genes or substances made by genes that may be involved in Diabetes Mellitus Type II with the purpose of improving the investigators understanding of the illness potentially leading to the development of new diagnostic tools for identifying the illness, new treatments,or preventative measures.
Conditions Studied
Study Locations (11)
Indiana
- American Health Network - Avon
- Investigator's Research Group - Brownsburg
- American Health Network - Franklin
- American Health Network - Greenfield
- American Health Network - Indianapolis
- Krannert Cardiology - Indianapolis
- Oral Health Research Institute - Indianapolis
- IU School of Medicine/CTSI - Indianapolis (Downtown)
- Alivio Medical Center - Indianapolis (Spanish Speaking)
- IU Medical Group - Indianapolis (Spanish/English Speaking)
- American Health Network - Muncie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2009-12 |
| Est. Completion | 2050-06 |
What the registry record for NCT01386801 still lists
NCT01386801 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 97-participant average among 7 other Diabetes Mellitus Type II trials with a reported enrollment target (931% higher).
The record links to 1 condition, with Diabetes Mellitus Type II appearing as the primary indexed condition, and to 0 interventions.
NCT01386801 lists 11 locations in 1 state (Indiana).
Frequently Asked Questions
What is clinical trial NCT01386801 about?
NCT01386801 is a clinical study titled "Multicenter Research Study to Build a Repository to Study Chronic Diseases in Indiana". Blood samples and health information (e.g., age at diagnosis, test results) are collected for the purposes of genetic research. The blood samples are assigned a number and stored in a repository for safe keeping until they are needed for a research project. Participants are persons who are healthy (...
What is the current status of trial NCT01386801?
This trial is currently active not recruiting. The enrollment target is 1,000 participants. The study started on 2009-12. Estimated completion is 2050-06.
What conditions does trial NCT01386801 study?
This clinical trial studies the following conditions: Diabetes Mellitus Type II.
Who is sponsoring clinical trial NCT01386801?
This trial is sponsored by Fairbanks Institute, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01386801 being conducted?
This trial has 11 study locations across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus Type II
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
RECRUITING · NA
-
Evaluate HM-002-1005 in Subjects With Type 2 Diabetes Mellitus
COMPLETED · Phase 1
-
Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics
COMPLETED · Phase 4
-
Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus
COMPLETED · Phase 2
-
GOLO Open-Label Pilot 1
COMPLETED · NA
-
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia